Teva Wants Out of Case Targeting Blockbuster MS Drug
Teva Pharmaceuticals Ltd. said Thursday it should be able to escape insurance payor claims alleging an elaborate campaign to suppress generic competition for Teva's multiple sclerosis drug Copaxone, arguing the claims...To view the full article, register now.
Already a subscriber? Click here to view full article